These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22064918)

  • 1. Therapeutic potential of intravenously administered human mesenchymal stromal cells.
    Kollar K; Seifried E; Henschler R
    Hamostaseologie; 2011 Nov; 31(4):269-74. PubMed ID: 22064918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression by mesenchymal stromal cells: from culture to clinic.
    Jones BJ; McTaggart SJ
    Exp Hematol; 2008 Jun; 36(6):733-41. PubMed ID: 18474304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.
    Müller I; Kordowich S; Holzwarth C; Isensee G; Lang P; Neunhoeffer F; Dominici M; Greil J; Handgretinger R
    Blood Cells Mol Dis; 2008; 40(1):25-32. PubMed ID: 17869550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations.
    Psaltis PJ; Paton S; See F; Arthur A; Martin S; Itescu S; Worthley SG; Gronthos S; Zannettino AC
    J Cell Physiol; 2010 May; 223(2):530-40. PubMed ID: 20162565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of genetically modified mesenchymal stem cells.
    Kumar S; Chanda D; Ponnazhagan S
    Gene Ther; 2008 May; 15(10):711-5. PubMed ID: 18356815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.
    Gonzalo-Daganzo R; Regidor C; Martín-Donaire T; Rico MA; Bautista G; Krsnik I; Forés R; Ojeda E; Sanjuán I; García-Marco JA; Navarro B; Gil S; Sánchez R; Panadero N; Gutiérrez Y; García-Berciano M; Pérez N; Millán I; Cabrera R; Fernández MN
    Cytotherapy; 2009; 11(3):278-88. PubMed ID: 19308773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats.
    Aksu AE; Horibe E; Sacks J; Ikeguchi R; Breitinger J; Scozio M; Unadkat J; Feili-Hariri M
    Clin Immunol; 2008 Jun; 127(3):348-58. PubMed ID: 18387852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: current status and future perspectives.
    Abdallah BM; Kassem M
    J Cell Physiol; 2009 Jan; 218(1):9-12. PubMed ID: 18726996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune properties of mesenchymal stem cells.
    Sotiropoulou PA; Papamichail M
    Methods Mol Biol; 2007; 407():225-43. PubMed ID: 18453259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y; Deng YB; Huang YJ; Wang Y
    Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population.
    Lucchini G; Introna M; Dander E; Rovelli A; Balduzzi A; Bonanomi S; Salvadè A; Capelli C; Belotti D; Gaipa G; Perseghin P; Vinci P; Lanino E; Chiusolo P; Orofino MG; Marktel S; Golay J; Rambaldi A; Biondi A; D'Amico G; Biagi E
    Biol Blood Marrow Transplant; 2010 Sep; 16(9):1293-301. PubMed ID: 20350611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune effects of mesenchymal stem cells: implications for Charcot-Marie-Tooth disease.
    Leal A; Ichim TE; Marleau AM; Lara F; Kaushal S; Riordan NH
    Cell Immunol; 2008; 253(1-2):11-5. PubMed ID: 18627903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease.
    McTaggart SJ; Atkinson K
    Nephrology (Carlton); 2007 Feb; 12(1):44-52. PubMed ID: 17295660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT).
    Hoogduijn MJ; Popp FC; Grohnert A; Crop MJ; van Rhijn M; Rowshani AT; Eggenhofer E; Renner P; Reinders ME; Rabelink TJ; van der Laan LJ; Dor FJ; Ijzermans JN; Genever PG; Lange C; Durrbach A; Houtgraaf JH; Christ B; Seifert M; Shagidulin M; Donckier V; Deans R; Ringden O; Perico N; Remuzzi G; Bartholomew A; Schlitt HJ; Weimar W; Baan CC; Dahlke MH;
    Transplantation; 2010 Jul; 90(2):124-6. PubMed ID: 20606604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow mesenchymal stem cells reduce the antitumor activity of cytokine-induced killer/natural killer cells in K562 NOD/SCID mice.
    Li Y; Qu YH; Wu YF; Wang XP; Wei J; Huang WG; Zhou DH; Fang J; Huang K; Huang SL
    Ann Hematol; 2011 Aug; 90(8):873-85. PubMed ID: 21234566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.
    Kassis I; Grigoriadis N; Gowda-Kurkalli B; Mizrachi-Kol R; Ben-Hur T; Slavin S; Abramsky O; Karussis D
    Arch Neurol; 2008 Jun; 65(6):753-61. PubMed ID: 18541795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How do mesenchymal stromal cells exert their therapeutic benefit?
    Horwitz EM; Dominici M
    Cytotherapy; 2008; 10(8):771-4. PubMed ID: 19089685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
    Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials.
    Brooke G; Rossetti T; Pelekanos R; Ilic N; Murray P; Hancock S; Antonenas V; Huang G; Gottlieb D; Bradstock K; Atkinson K
    Br J Haematol; 2009 Feb; 144(4):571-9. PubMed ID: 19077161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells: biological properties and clinical applications.
    García-Gómez I; Elvira G; Zapata AG; Lamana ML; Ramírez M; Castro JG; Arranz MG; Vicente A; Bueren J; García-Olmo D
    Expert Opin Biol Ther; 2010 Oct; 10(10):1453-68. PubMed ID: 20831449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.